|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600119405 |
|
最近更新日期: Date of Last Refreshed on: |
2026-02-26 15:30:37 |
|
注册时间: Date of Registration: |
2026-02-26 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
下颌骨单纯性囊肿非手术治疗病例报道一例 |
|
Public title: |
Spontaneous Resolution of a Simple Bone Cyst in the Anterior Mandible: A Case Report and Literature Review. |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
下颌骨单纯性囊肿非手术治疗病例报道一例 |
|
Scientific title: |
Spontaneous Resolution of a Simple Bone Cyst in the Anterior Mandible: A Case Report and Literature Review. |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
魏志斌 |
研究负责人: |
周丽斌 |
|
Applicant: |
Zhibin Wei |
Study leader: |
Libin Zhou |
|
申请注册联系人电话: Applicant telephone: |
+86 136 4027 8310 |
研究负责人电话: Study leader's telephone: |
+86 136 0003 6973 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
bin393158759@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
fmmumario@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广州市越秀区东风西路 195 号 |
研究负责人通讯地址: |
广州市越秀区东风西路 195 号 |
|
Applicant address: |
195 Dongfengxi Road, Yuexiu District, Guangzhou, China |
Study leader's address: |
195 Dongfengxi Road, Yuexiu District, Guangzhou, China |
|
申请注册联系人邮政编码: Applicant postcode: |
510500 |
研究负责人邮政编码: Study leader's postcode: |
510500 |
|
申请人所在单位: |
广州医科大学附属口腔医院 |
||
|
Applicant's institution: |
Stomatological Hospital of Guangzhou Medical University |
||
|
研究负责人所在单位: |
广州医科大学附属口腔医院 |
||
|
Affiliation of the Leader: |
Stomatological Hospital of Guangzhou Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
LCYJ20250303006 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
广州医科大学附属口腔医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Stomatological Hospital Affiliated to Guangzhou Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-03-03 00:00:00 |
||
|
伦理委员会联系人: |
方志夫 |
||
|
Contact Name of the ethic committee: |
Zhifu Fang |
||
|
伦理委员会联系地址: |
广州市越秀区东风西路 195 号 |
||
|
Contact Address of the ethic committee: |
195 Dongfengxi Road, Yuexiu District, Guangzhou, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 132 8686 4061 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
广州医科大学附属口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Stomatological Hospital of Guangzhou Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广州市越秀区东风西路 195 号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
195 Dongfengxi Road, Yuexiu District, Guangzhou, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||
|
Source(s) of funding: |
None |
||||||||||||||||||||||
|
Target disease: |
Simple Bone Cyst |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
病例研究 |
||||||||||||||||||||||
|
Study design: |
Case study |
||||||||||||||||||||||
|
研究目的: |
探讨颌骨小范围单纯性囊肿非手术治疗的长期跟踪随访治疗效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
To Explore the Long-term Follow-up Efficacy of Non-surgical Treatment for Small-scale Simple Cysts of the Jawbone |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
无 |
||||||||||||||||||||||
|
Inclusion criteria |
None |
||||||||||||||||||||||
|
排除标准: |
无 |
||||||||||||||||||||||
|
Exclusion criteria: |
None |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-01-21 00:00:00至 To 2024-08-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-08-01 00:00:00 至 To 2024-08-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
公开发布原始数据的日期为研究论文正式发表后 1 个月内,通过 Figshare(国际开放数据平台)共享原始数据(含元数据、研究方案),平台网址为https://figshare.com |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The raw data (including metadata and study protocol) will be shared via Figshare (a web-based public data platform) within 1 month after the official publication of the research paper. The platform URL is https://figshare.com |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表(CRF):采用定制化纸质 CRF,内容涵盖患者基本信息、术前纳入 / 排除标准核查记录、麻醉方案信息、术中操作记录、术后 VAS 疼痛评分、PoSSe 量表得分及不良反应记录等核心数据,由经过培训的研究人员规范填写; 电子数据采集和管理系统(EDC):使用 ResMan(基于互联网的 EDC 系统)进行数据电子化录入,完成数据的实时核查、逻辑校验与安全存储,保障数据的完整性与可追溯性 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form (CRF): A customized paper CRF will be used, covering core data such as patients' basic information, pre-operative inclusion/exclusion criteria verification records, anesthesia protocol information, intra-operative operation records, postoperative VAS pain scores, PoSSe scale scores and adverse reaction records, which will be filled out standardized by trained researchers; Electronic Data Capture (EDC): ResMan (an internet-based EDC system) will be adopted for electronic data entry, realizing real-time data verification, logical validation and secure storage to ensure data integrity and traceability |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |